MedCheck No 28 (December 2023) Download PDF Free
Contents
Editorial
Unavoidable adverse reactions to Alzheimer’ s agent
Review
Lecanemab removes substitute of lost cells leading to brain
hemorrhage and atrophy
Vaccine Information
Is it true： “Several vaccines reduce Alzheimer’ s disease” ?
Beware of distortion by healthy-vaccine effect
New Products
GLP-1 agonist for obesity: Semaglutide (Wegovy)
Too many adverse effects including suicide. Do not use ！
Errata for line 13-14, left column on p54 (PDF is already corrected)
Before:
Adrenergic-mediated action is essential for weight
loss with GLP-1 agonists [16].
Corrected:
Adrenergic-mediated action is essential for weight
loss with GLP-1 agonists, because GLP-1 did not decrease
body weight of triple beta-adrenoreceptor knockout
mice [16]
